Anthera Pharmaceuticals Probability of Future Pink Sheet Price Finishing Over 1.0E-4
ANTHDelisted Stock | USD 0.0001 0.00 0.00% |
Anthera |
Anthera Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Anthera Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Anthera Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Anthera Pharmaceuticals is not yet fully synchronised with the market data | |
Anthera Pharmaceuticals has some characteristics of a very speculative penny stock | |
Anthera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (26.87 M) with loss before overhead, payroll, taxes, and interest of (28.49 M). | |
Anthera Pharmaceuticals currently holds about 8.09 M in cash with (36.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Anthera Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Anthera Pink Sheet often depends not only on the future outlook of the current and potential Anthera Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anthera Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 10.3 M | |
Cash And Short Term Investments | 2.2 M | |
Shares Float | 26.1 M |
Anthera Pharmaceuticals Technical Analysis
Anthera Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Anthera Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Anthera Pharmaceuticals. In general, you should focus on analyzing Anthera Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Anthera Pharmaceuticals Predictive Forecast Models
Anthera Pharmaceuticals' time-series forecasting models is one of many Anthera Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Anthera Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Anthera Pharmaceuticals
Checking the ongoing alerts about Anthera Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Anthera Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Anthera Pharmaceuticals is not yet fully synchronised with the market data | |
Anthera Pharmaceuticals has some characteristics of a very speculative penny stock | |
Anthera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (26.87 M) with loss before overhead, payroll, taxes, and interest of (28.49 M). | |
Anthera Pharmaceuticals currently holds about 8.09 M in cash with (36.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Anthera Pink Sheet
If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |